Access

Perspective

Nature Reviews Cancer 8, 957–967 (1 December 2008) | doi:10.1038/nrc2523

|[gamma]|H2AX and cancer

William M. Bonner , Christophe E. Redon , Jennifer S. Dickey , Asako J. Nakamura , Olga A. Sedelnikova , St|[eacute]|phanie Solier & Yves Pommier

Histone H2AX phosphorylation on a serine four residues from the carboxyl terminus (producing γH2AX) is a sensitive marker for DNA double-strand breaks (DSBs). DSBs may lead to cancer but, paradoxically, are also used to kill cancer cells. Using γH2AX detection to determine the extent of DSB induction may help to detect precancerous cells, to stage cancers, to monitor the effectiveness of cancer therapies and to develop novel anticancer drugs.